IgE cross-linking critically impairs human monocyte function by blocking phagocytosis - 30/01/13
Abstract |
Background |
IgE cross-linking triggers many cellular processes that drive allergic disease. While the role of IgE in mediating allergic responses is best described on basophils and mast cells, expression of the high-affinity IgE receptor on other innate immune cells, including monocytes, suggests that it may affect the function of these cells in allergic environments.
Objective |
To determine the effect of IgE cross-linking on the function of human monocytes.
Methods |
Monocytes purified from healthy donor blood samples were cultured for 4 to 96 hours with media alone, a cross-linking anti-IgE antibody or control IgG. Surface CD14 and CD64 expression and secreted cytokine concentrations were determined. Monocyte function was determined by assessing (1) phagocytosis of Escherichia coli or apoptotic HEp2 cells and (2) killing of intracellular E coli. Select experiments were performed on monocytes obtained from participants with elevated versus normal serum IgE concentrations.
Results |
IgE cross-linking on monocytes increased CD14 expression and induced secretion of TNF-⍺, IL-6, and autoregulatory IL-10. These effects were greatest in individuals with elevated serum IgE concentrations. In contrast, IgE cross-linking reduced CD64 expression and significantly impaired phagocytic function without disrupting the capacity of monocytes to kill bacteria.
Conclusions |
IgE cross-linking drives monocyte proinflammatory processes and autoregulatory IL-10 in a serum IgE-dependent manner. In contrast, monocyte phagocytic function is critically impaired by IgE cross-linking. Our findings suggest that IgE cross-linking on monocytes may contribute to allergic disease by both enhancing detrimental inflammatory responses and concomitantly crippling phagocytosis, a primary mechanism used by these cells to resolve inflammation.
Le texte complet de cet article est disponible en PDF.Key words : Monocyte, IgE, FcεRI, IgE cross-linking, allergy, proinflammatory, autoregulatory, phagocytosis, apoptotic debris
Abbreviations used : ⍺IgE, CFSE, LPS, pDC, SHIP, TLR
Plan
This study was supported by the William A. Sellars and Joyce M. Sellars Distinguished Chair in Allergy and Immunology; National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) grant no. R01-AI098077; NIH/NIAID grant no. R01-AI056222; NIH National Research Service Award no. T32-AI005284; and NIH National Institute of General Medical Sciences grant no. T32-GM008014. |
|
Disclosure of potential conflict of interest: D. M. Pyle has received research support from the National Institutes of Health National Research Service Award and the National Institute of General Medical Sciences. R. S. Gruchalla has received research support from the William A. Sellars and Joyce M. Sellars Distinguished Chair in Allergy and Immunology and the National Institutes of Health Inner City Asthma Consortium and is employed by the Food and Drug Association on an as-needed basis. J. D. Farrar and M. A. Gill have received research support from the National Institutes of Health, National Institute of Allergy and Infectious Diseases. V. S. Yang declares that she has no relevant conflicts of interest. |
Vol 131 - N° 2
P. 491 - février 2013 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?